Possible risks of taking berberine and semaglutide together include increased gastrointestinal side effects such as nausea and diarrhea, low blood sugar (mainly if you also take insulin or other diabetes medications), and potential effects on how your body absorbs other oral medications
Nausea peaks
For moderate weight loss with minimal side effects, a maintenance dose of 4mg provides 17% body weight reduction with a tolerable side effect profile
GLOW GHK-Cu / BPC-157 / TB-500 GLP-3 RT 30mg KLOW KLOW is a high-purity research blend combining GHK-Cu, BPC-157, TB-4, and KPV (50 mg/10 mg/10 mg/10 mg), supplied for laboratory applications and commonly mentioned in tissue repair and regeneration research
Gut hormone analog medications such as liraglutide, semaglutide, and tirzepatide target the GLP-1 receptor, with tirzepatide also targeting the glucose-dependent insulinotropic polypeptide receptor